• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deal search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • Q&A
    • Videos
    • Comment
    • Analysis
    • People moves
    • In Profile
  •  
    Analysis
    • Videos
    • Q&A
    • Comment
    • In Profile
    • Podcast
    • Fundraising
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
      • Deals search
      • Exits search
      • Funds search
      • Sponsors search
      • Advisers search
      • LPs search
      • League tables
      • Reports
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
UNQUOTE
  • Healthcare

Private equity nursing healthcare providers

Private equity nursing healthcare providers
  • Greg Gille
  • 22 March 2011
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

The beginning of the year has seen private equity investors eager to tap into Europe’s healthcare services market, with a string of deals being completed both in the UK and on the continent. Could this growing and resilient sector be the perfect investment in a troubled economic climate? Greg Gille reports

While the life sciences sector largely remains the turf of venture houses and highly specialised funds, it would seem that generalist players have woken up to the possibilities offered by another growing segment of the healthcare market. Although signs of the renewed interest for the sector were already visible towards the end of last year, 2011 started with a flurry of investments in private healthcare providers.

Advent International kicked things off in January with the £925m buyout of Priory Group from RBS. The mental health and specialist care services provider apparently turned a few heads around as Advent had to fend off competition from rival firms such as Bain, Blackstone and Cinven in the auction process. This is a testament to Priory's health: the company posted a £123.3m turnover in 2002, which had doubled to £242.2m by 2008 and further increased to £256.7m in 2009. Its profits also rose from £40.7m in 2008 to £86m the following year.

Still in the UK, Carlyle is building a dental care giant with its acquisition of Integrated Dental Holdings from Bank of America Merrill Lynch Capital Partners. It is merging it with Palamon-backed Associated Dental Practices and the enlarged group will be worth around £600m, roughly 10x its £55-60m combined EBITDA.

Across the pond, the French private clinics market also looks attractive to Bridgepoint, as the firm announced two investments earlier this month: its mid-market team Bridgepoint Development Capital (BDC) acquired a majority stake in clinics operator Compagnie Stéphanoise de Santé (C2S), while Bridgepoint Europe IV backed the OBO of Médipôle Sud Santé - a deal that valued the company at more than €200m. Retirement homes and homecare providers also proved popular over the past few months, with a number of smaller deals being completed.

At a time when buyout houses are on the lookout for resilient assets, able to make the most of a lacklustre economic environment, the European private healthcare market trends seem increasingly attractive to investors: "We had been looking at the private clinics sector for a long time. It benefits from favourable demographic trends - you can reliably count on a 2-3% market growth per year. This visibility is hard to come by in other sectors," notes BDC partner Pierre Colasson, who led the acquisition of C2S.

An ageing population and demand for better patient care aside, private healthcare providers are also likely to benefit from the ongoing efforts undertaken by European governments to tackle deficits and ease the burden of costly public establishments. This is particularly relevant in the UK - with the coalition government looking to significantly downsize the public sector - and was one of the factors at play in the buyout of Priory: Advent believes private healthcare providers are likely to be commissioned to supply an increasing number of services on behalf of the public sector over the coming year.

This is not to say that the sector is a particularly easy one to penetrate, as it is often capital-intensive and requires GPs to navigate tight regulatory frameworks. This can, however, be viewed as another strength, according to Colasson: "The heavily regulated nature of the market - which presents a few drawbacks, notably in terms of prices charged for the services - can also be seen as an attractive factor, since it guarantees high barriers to entry." By limiting competition, this could enable GPs already invested in the market to take advantage of the consolidation opportunities it offers.

Indeed, the private healthcare services sector is for the moment rather fragmented, with a myriad of small independent outfits operating on a local scale - quite similar in that regard to the recruitment services market, which also witnessed several buy-and-build transactions taking place at the end of 2010. This was another key driver in most of the aforementioned deals, as private equity owners will look for relevant bolt-ons in order to benefit from both economies of scale and a wider customers base.

Dealflow in the healthcare services sector should therefore keep investors busy in the coming months, as today's buyouts pave the way for tomorrow's acquisition finance deals.

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Healthcare
  • Bridgepoint
  • Advent International
  • Carlyle Group

More on Healthcare

Gyrus Capital acquires LRE Medical from KPS-backed AIS Global
Gyrus Capital acquires LRE Medical from KPS-backed AIS Global

Carve-out of German diagnostic equipment manufacturer comes over two years after first sale attempt

  • Healthcare
  • 26 May 2023
Forbion raises combined EUR 1.35bn for venture and growth funds
Forbion raises combined EUR 1.35bn for venture and growth funds

Ventures Fund VI closes on EUR 750m and Growth Opportunities II on EUR 600m with both upsized by over 60%

  • Healthcare
  • 19 April 2023
EQT closes LSP Dementia on EUR 260m hard cap
EQT closes LSP Dementia on EUR 260m hard cap

Series A-focused fund exceeded its EUR 100m target and extended fundraising after increased LP interest in its strategy

  • Healthcare
  • 30 March 2023
Ardian reinvests in Neopharmed alongside NB Renaissance
Ardian reinvests in Neopharmed alongside NB Renaissance

French GP will move stake from fund VI to VII; additional capital allows for European M&A

  • Healthcare
  • 10 November 2022

Latest News

Partners Group to release IMs for Civica sale in mid-September
  • Exits
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
BHM Group builds on PE strategy, eyes European medtech and renewable energy acquisitions
  • Investments
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Czech Republic-headquartered family office is targeting DACH and CEE region deals

  • 01 September 2023
Redalpine expands leadership team amid CHF 1bn-plus fundraise
  • Venture
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO

  • 31 August 2023
Change Ventures aims to hold final close for EUR 20m third fund by mid-2024
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds

  • 31 August 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013